Cargando…
A predictive model to estimate fever after receipt of the second dose of Pfizer‐BioNTech coronavirus disease 2019 vaccine: An observational cohort study
BACKGROUND AND AIMS: Fever after coronavirus disease 2019 (COVID‐19) vaccination is generally a mild and benign event, but can cause excessive anxiety in younger adults. This study aimed to find key factors that include allergic diseases or physique that determine fever after vaccination. METHODS: W...
Autores principales: | Chiba, Satoru, Shinohara, Kaoru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9297380/ https://www.ncbi.nlm.nih.gov/pubmed/35873402 http://dx.doi.org/10.1002/hsr2.742 |
Ejemplares similares
-
Portal vein thrombosis after second Pfizer/BioNTech coronavirus disease 2019 vaccine
por: Petrochko, Jameson M., et al.
Publicado: (2022) -
Recurring Weakness in Rhabdomyolysis Following Pfizer–BioNTech Coronavirus Disease 2019 mRNA Vaccination
por: Kimura, Motoya, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)